Search results
Results From The WOW.Com Content Network
Zoonotic influenza vaccine Seqirus is authorized for use in the European Union. [1] It contains a flu strain called A/Astrakhan/3212/2020 (H5N8)-like strain (CBER-RG8A) (clade 2.3.4.4b). [ 1 ] Zoonotic influenza vaccine Seqirus was considered to be the best candidate to provide protection against circulating H5 influenza A strains.
Pandemrix is an influenza vaccine for influenza pandemics, such as the 2009 flu pandemic. The vaccine was developed by GlaxoSmithKline (GSK) [2] and patented in September 2006. [3] The vaccine was one of the H1N1 vaccines approved for use by the European Commission in September 2009, upon the recommendations of the European Medicines Agency ...
The H1N1 swine-flu vaccine, Pandemrix, used the adjuvant branded AS03, which has squalene (10.69 milligrams), DL-α-tocopherol (11.86 milligrams) and polysorbate 80 (4.86 milligrams) [28] Preservatives
Swine flu is being billed as a potential killer this winter, but health officials still tell us the best public defense is washing our hands. Everyone should get H1N1 flu shots, the feds say, yet ...
During the H1N1 swine flu pandemic, much criticism was leveled at health officials accusing them of making recommendations that were too heavily influenced by the pharmaceutical industry -- a ...
U.S. President Gerald Ford receiving his vaccine for the swine flu. The US swine flu immunization campaign in response to the 1976 swine flu outbreak has become known as "the swine flu fiasco" because the outbreak did not lead to a pandemic as US President Gerald Ford had feared and the hastily rolled out vaccine was found to increase the ...
AS03 (for "Adjuvant System 03") is the trade name for a squalene-based immunologic adjuvant used in various vaccine products by GlaxoSmithKline (GSK). It is used, for example, in GSK's A/H1N1 pandemic flu vaccine Pandemrix. It is also in Arepanrix and the Q-pan for H5N1 influenza. [1] A dose of AS03 adjuvant contains [2] 10.69 mg squalene
Under the multi-year contract CSL will deliver its MF59 adjuvant, an ingredient that can be used to manufacture vaccines against the H5 avian influenza virus. ... (HHS) worth $121.4 million to ...